gRNA (guide RNA) is an RNA molecule used in genome-editing technologies, such as the CRISPR-Cas9 system. Along with the Cas enzyme, gRNA helps in recognizing and cleaving specific DNA sequences. Due to its customizability, efficiency, and versatility, gRNA is an essential component of genome-editing technologies.
When it comes to gRNA for therapeutic applications, purity is a critical factor.
For therapeutic applications, regulatory agencies will look for the use of reagents at the best available purity, regardless of in-vivo or ex-vivo use.
Former Executive, Biotech
Regulators now require at least 80% purity and a well-designed analytical control strategy.
VP, Quality, Biotech
“High purity is important.” “Using 1.5 times the required quantity of a 60% pure gRNA does not provide the same activity as a 90% pure gRNA.”
Professor at an academic institution
There are multiple advantages in using high purity gRNA—easier to work with, easier to characterize, and lower probability of off-target effects.
VP, Quality, Biotech
In case of 100 mer synthesis, TBDMS chemistry produces about four times as many 2’, カジノ シークレット 出 金 時間switched isomers as PMM chemistry.
TBDMS group is more labile than PMM group under acidic condition. Thus, TBDMS chemistry leads to more 2’, カジノ シークレット 出 金 時間switched isomers as described in figure 1*.
*Mass Spectrometry Reviews, 2021, 40, 75–109
With its unique technologies, Sumitomo achieves unmatched purity in the production of gRNAs for therapeutic applications.